Brief: Pulse Biosciences Announces FDA IDE Approval To Initiate Its nsPFA Cardiac Surgery System Study For The Treatment Of Atrial Fibrillation
08/09/2025 12:42
Sept 8 (Reuters) - Pulse Biosciences Inc PLSE.O: PULSE BIOSCIENCES ANNOUNCES FDA IDE APPROVAL TO INITIATE ITS NSPFA CARDIAC SURGERY SYSTEM STUDY FOR THE TREATMENT OF ATRIAL FIBRILLATION Source text: ID:nBw8LzHyYa Further company coverage: PLSE.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pulse Biosciences
See all newsUS RESEARCH ROUNDUP-Affiliated Managers Group, Goldman Sachs, Vaxcyte
Pulse Biosciences Inc reports results for the quarter ended June 30 - Earnings Summary
Pulse Biosciences Q2 net loss widens, cash position strengthens
Pulse Biosciences Inc expected to post a loss of 36 cents a share - Earnings Preview
Brief: Pulse Biosciences, Inc. Announces Planned Redemption Of Warrants